Leaflet ALVESCO 160 INHALER 160mcg / dose pressurized inhalation solution

Product code:
W64226001
Quantity:
1
Indicated for:
asthma; allergic rhinitis
Route of administration:
inhalation
Substance:
ciclesonide (glucocorticoid)
ATC
R03BA08 — Respiratory system | Other drugs for obstructive airway diseases, inhalants | Glucocorticoids
Ciclesonide is a glucocorticoid used for the treatment of asthma and allergic rhinitis. It works by reducing inflammation in the airways, alleviating symptoms such as breathing difficulties and nasal congestion.

The medication is administered as an inhaler or nasal spray, as directed by a doctor. It is important for patients to use the medication regularly to achieve maximum benefits.

Patients should be aware of potential side effects, such as throat irritation, hoarseness, or nasal dryness. It is important to inform the doctor of any unusual symptoms.

Common side effects include throat irritation, hoarseness, and nasal dryness. In rare cases, severe reactions such as oral fungal infections or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about ALVESCO 160 INHALER 160mcg / dose

Substance:
ciclesonide
Date of latest medicines list:
01-06-2026
Product code:
W64226001
Concentration:
160mcg / dose
Pharmaceutical form:
pressurized inhalation solution
Quantity:
1
Product type:
Original
Price:
94.72 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
TAKEDA GMBH - GERMANIA
Holder:
ASTRAZENECA AB - SUEDIA
Number:
9031/2016/01
Shelf life:
3 years

Concentrations available for ciclesonide

  • 160mcg/dose
  • 40mcg/dose
  • 80mcg/dose

Compensation lists for ALVESCO 160 INHALER 160mcg / dose AstraZeneca

B - Sublist B with 50% discount from the reference price

Price
94.72 RON
Copayment
44.54 RON
Patient
50.19 RON